{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:22:03Z","timestamp":1769354523933,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stiftung P. E. Kempkes","award":["01\/2021"],"award-info":[{"award-number":["01\/2021"]}]},{"name":"Stiftung P. E. Kempkes","award":["03\/2022 MR"],"award-info":[{"award-number":["03\/2022 MR"]}]},{"DOI":"10.13039\/501100009560","name":"University Medical Center Giessen and Marburg","doi-asserted-by":"publisher","award":["01\/2021"],"award-info":[{"award-number":["01\/2021"]}],"id":[{"id":"10.13039\/501100009560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009560","name":"University Medical Center Giessen and Marburg","doi-asserted-by":"publisher","award":["03\/2022 MR"],"award-info":[{"award-number":["03\/2022 MR"]}],"id":[{"id":"10.13039\/501100009560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinician Scientist program (SUCCESS-program) of Philipps-University","award":["01\/2021"],"award-info":[{"award-number":["01\/2021"]}]},{"name":"Clinician Scientist program (SUCCESS-program) of Philipps-University","award":["03\/2022 MR"],"award-info":[{"award-number":["03\/2022 MR"]}]},{"name":"University Hospital Giessen and Marburg (UKGM)","award":["01\/2021"],"award-info":[{"award-number":["01\/2021"]}]},{"name":"University Hospital Giessen and Marburg (UKGM)","award":["03\/2022 MR"],"award-info":[{"award-number":["03\/2022 MR"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["01\/2021"],"award-info":[{"award-number":["01\/2021"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["03\/2022 MR"],"award-info":[{"award-number":["03\/2022 MR"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Purpose: the aim of this cross-sectional study was to analyze the impact of the COVID-19 pandemic on Cervical Cancer Screening (CCS) in gynecological practices in Germany. Methods: The basis of the analysis was the Uniform Evaluation Standard (EBM) of the Statutory Health Insurance Scheme. This cross-sectional study included all women aged \u226520 years with at least one CCS (clinical and cytological examination) in 223 gynecological practices in Germany during the period 2018\u20132021. The number of patients with CCS per practice was shown for each year. The average number of patients per year was compared between the pre-pandemic time period (2018, 2019) and the pandemic time period (2020, 2021) using Wilcoxon tests. Analyses were conducted separately for clinical investigations and cytological investigations and were also stratified by age group (20\u201334, 35\u201350, &gt;50 years). Results: CCS in gynecological practices significantly decreased in Germany between the pre-pandemic time period of 2018\u20132019 and the pandemic years of 2020\u20132021. This decrease was observed in all age groups but was stronger in women aged 20\u201334 (\u221225.6%) and weaker in women aged &gt;50 (\u221215.2%). Conclusions: We found a statistically and clinically relevant decrease of patients receiving CCS in gynecological practices in Germany. This finding is even more exceptional because the new screening algorithm with direct invitations for each patient started in 2020 and was supposed to lead to a higher number of patients in its first years. However, the observed decline in the detection of cervical precancer lesions may lead to increased cervical cancer burden. Risk-based screening strategies and further measures are necessary to adapt to the ongoing COVID-19 pandemic and return to pre-pandemic CCS numbers.<\/jats:p>","DOI":"10.3390\/cancers14194820","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:07:43Z","timestamp":1665187663000},"page":"4820","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Screening in Gynecological Practices in Germany"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-3646","authenticated-orcid":false,"given":"Niklas","family":"Gremke","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstra\u00dfe, 35043 Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Griewing","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstra\u00dfe, 35043 Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Felgentreff","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstra\u00dfe, 35043 Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-7227","authenticated-orcid":false,"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[{"name":"Epidemiology, IQVIA, Main Airport Center, Unterschweinstiege 2-14, 60549 Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kalder","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstra\u00dfe, 35043 Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00103-018-2835-7","article-title":"Geb\u00e4rmutterhalskrebsscreening in Deutschland","volume":"61","author":"Klug","year":"2018","journal-title":"Bundesgesundheitsblatt\u2014Gesundh.\u2014Gesundh."},{"key":"ref_4","unstructured":"Barnes, B., Kraywinkel, K., Nowossadeck, E., Sch\u00f6nfeld, I., Starker, A., Wienecke, A., and Wolf, U. (2016). Bericht zum Krebsgeschehen in Deutschland 2016."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/eurpub\/cki163","article-title":"The German cervical cancer screening model: Development and validation of a decision-analytic model for cervical cancer screening in Germany","volume":"16","author":"Siebert","year":"2006","journal-title":"Eur. J. Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-014-3421-3","article-title":"Cervical cancer screening in Germany: Group-specific participation rates in the state of Niedersachsen (Lower Saxony). A study with health insurance data","volume":"291","author":"Geyer","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5455\/msm.2020.32.62-65","article-title":"Implementation of the Program for Early Detection of Cervical Cancer in the Federal Republic of Germany","volume":"32","author":"Hrgovic","year":"2020","journal-title":"Mater. SocioMed."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2147\/IJWH.S288376","article-title":"Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer","volume":"13","author":"Lozar","year":"2021","journal-title":"Int. J. Womens Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3257939","DOI":"10.1155\/2019\/3257939","article-title":"Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives","volume":"2019","author":"Chan","year":"2019","journal-title":"J. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/ijc.22114","article-title":"Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands","volume":"119","author":"Bos","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/djn099","article-title":"Screening-preventable cervical cancer risks: Evidence from a nationwide audit in Sweden","volume":"100","author":"Andrae","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/eurpub\/ckm043","article-title":"Invasive cervical cancer: A failure of screening","volume":"18","author":"Spayne","year":"2008","journal-title":"Eur. J. Public Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41591-022-01750-1","article-title":"COVID-19 and resilience of healthcare systems in ten countries","volume":"28","author":"Arsenault","year":"2022","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-021-01381-y","article-title":"Health systems resilience in managing the COVID-19 pandemic: Lessons from 28 countries","volume":"27","author":"Haldane","year":"2021","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jacob, L., Loosen, S.H., Kalder, M., Luedde, T., Roderburg, C., and Kostev, K. (2021). Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany. Cancers, 13.","DOI":"10.3390\/cancers13030408"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/S2468-2667(21)00078-5","article-title":"Cervical screening during the COVID-19 pandemic: Optimising recovery strategies","volume":"6","author":"Castanon","year":"2021","journal-title":"Lancet Public Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0969141320974711","article-title":"The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada","volume":"28","author":"Yong","year":"2021","journal-title":"J. Med. Screen."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2022.2617","article-title":"Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis","volume":"8","author":"Teglia","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5414\/CP203320","article-title":"Basic characteristics and representativeness of the German Disease Analyzer database","volume":"56","author":"Rathmann","year":"2018","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000509546","article-title":"The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology","volume":"88","author":"Guiot","year":"2021","journal-title":"Pathobiology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cncr.33274","article-title":"The future of cancer screening after COVID-19 may be at home","volume":"127","author":"Gorin","year":"2021","journal-title":"Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e21697","DOI":"10.2196\/21697","article-title":"The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities","volume":"6","author":"Cancino","year":"2020","journal-title":"JMIR Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nurpra.2016.08.036","article-title":"Cervical Cancer Screening Among Minorities in the United States","volume":"12","author":"Nardi","year":"2016","journal-title":"J. Nurse Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: Updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low Genit Tract Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Monaghesh, E., and Hajizadeh, A. (2020). The role of telehealth during COVID-19 outbreak: A systematic review based on current evidence. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09301-4"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106596","DOI":"10.1016\/j.ypmed.2021.106596","article-title":"Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities","volume":"151","author":"Wentzensen","year":"2021","journal-title":"Prev. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/19\/4820\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:45:26Z","timestamp":1760143526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/19\/4820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,2]]},"references-count":30,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cancers14194820"],"URL":"https:\/\/doi.org\/10.3390\/cancers14194820","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,2]]}}}